EE147 Complement C5 Inhibitor (Anti-C5) and Neonatal Fc Receptor Antagonist Anti-FcRn in Myasthenia Gravis at University Public Hospitals of Paris, France (AP-HP): What Is the Market Share of These New Treatments?
Abstract
Authors
Nawel KASBADJI ISABELLE FUSIER ALBANE DEGRASSAT THEAS Philippe Mougenot Pascal Paubel